Two FDA drug review Directors to leave the agency, with no permanent replacements in place
April 27, 2018Medical Communications, Sales and Marketing FDA, pharma
The FDA has revealed that two of its prominent Directors are set to retire from the agency, leaving three of …
Investigational Alexion drug proves non-inferior to Soliris in rare blood disease
April 27, 2018Medical Communications, Research and Development Alexion, paroxysmal nocturnal haemoglobinuria, pharma, soliris
Alexion has lifted the curtain on new data for its C5 complement inhibitor ALXN1210, demonstrating its non-inferiority to another of …
FDA moots a return look at Acadia’s lead drug
April 27, 2018Medical Communications, Sales and Marketing Acacia, FDA, nuplazid, pharma
Following a non-profit report that higher rates of death were associated with Acadia Pharmaceuticals’ Nuplazid, Scott Gottlieb has made comments …
Health to hand
April 26, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Breast Cancer Care, biotech, drugs, pharma, pharmaceutical
Kristina Barrick is the Digital Innovation Manager at Breast Cancer Care and leads on the development of BECCA, the Breast …
US court upholds verdict voiding MSD’s claim to $200m from Gilead in patent dispute
April 26, 2018Sales and Marketing Gilead, MSD, Merck, harvoni, hepatitis C, pharma, sovaldi
MSD has taken a legal hit after a US appeals court upheld a ruling that the pharma giant had illicitly …
House of Lords unloads both barrels on Government’s life science strategy approach
April 26, 2018Medical Communications ABPI, Life Sciences Industrial Strategy, UK government, biotech, drugs, pharma, pharmaceutical
The Life Sciences Industrial Strategy was supposed to forge a path forward for the industry, despite pressures from Brexit, to …
UK media coverage vastly underrepresents older cancer patients and their risk, study finds
April 26, 2018Medical Communications, Research and Development Cancer, Cancer Research UK, UK, University of Glasgow, pharma
A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients …
Takeda announce new UK MD, ahead of possible Shire transformation
April 26, 2018Medical Communications Shire, Takeda, biotech, drugs, pharma, pharmaceutical
“Jon’s appointment comes at an exciting time for the company” reads the company press on annoucing its new Managing Director …
Common antidepressants linked to dementia risk
April 26, 2018Medical Communications anticholinergic, biotech, dementia, drugs, pharma, pharmaceutical
A large study looking at the public’s use of anticholinergic drugs, such as those used to treat depression and Parkinson’s, …
Lilly’s arthritis drug found to prevent potentially lethal stem cell transplant complications
April 25, 2018Research and Development Cancer, Eli Lilly, JAK inhibitors, Stem cells, baricitinib, graft-versus-host disease, pharma
Researchers at St Louis Washington University School of Medicine have uncovered a promising extra application of a particular Janus Kinase …
Juno CEO and Co-founder steps down in wake of Celgene acquisition
April 25, 2018Medical Communications, Research and Development Celgene, appointment, juno therapeutics, pharma
Hans Bishop, CEO and Co-founder of Juno Therapeutics who helped set up the company in 2013 and has since grown …
Novartis forges forward into digital pharma with FocalView app
April 25, 2018Medical Communications, Research and Development FocalView, Novartis, biotech, drugs, pharma, pharmaceutical
There is a growing trend in big pharma to talk up the potential for digital technology to revolutionise operations and …
Sanofi makes ex-Roche scientist new R&D chief
April 25, 2018Medical Communications, Research and Development Roche, Sanofi, biotech, drugs, pharma, pharmaceutical
With the retirement of Elias Zerhouni as Head of Global R&D, Sanofi had to find a suitable replacement and believes …
$64bn Takeda-Shire mega merger inches closer to closing
April 25, 2018Research and Development, Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
From March onwards, Takeda has been nudging a deal with Shire onwards through repeatedly improved offers, which has seen the …
MHRA bans sodium valproate in the UK following birth defect controversy
April 24, 2018Manufacturing and Production, Research and Development, Sales and Marketing MHRA, Sanofi, Sodium valproate, bipolar, epilepsy, pharma
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced that sodium valproate, a drug used in the treatment …
Lilly’s arthritis drug hits trouble at FDA committee
April 24, 2018Manufacturing and Production, Sales and Marketing Eli Lilly, Incyte, biotech, drugs, pharma, pharmaceutical, rheumatoid arthritis
FDA’s advisory committee were openly conflicted about deciding on the safety of Eli Lilly and Incyte’s drug, baricitinib, for the …
AZ’s combo woes continue, with failure in lung cancer
April 24, 2018Manufacturing and Production, Research and Development AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical
AstraZeneca has been hit by a fresh blow in its search for an immunotherapy combination treatment that could differentiate it …
The May 2018 issue of Pharmafocus is now live!
April 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, MSD, Pharmafocus, Shire, Takeda, flypharma, keytruda, mhealth, mobile health summit, opdivo, pharma, sugar tax
Just in time for the first good weather of the year, the May 2018 edition of Pharmafocus is available to …
Prothena collapses on double trial failure
April 23, 2018Manufacturing and Production, Research and Development Prothena Therapeutics, biotech, drugs, pharma, pharmaceutical
Shares in Prothena have dropped by close to 70% on the news that two of its trials into its lead …
Living with atrial fibrillation
April 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KardiaMobile, Tony Green, atrial fibrillation, patient experience
Tony Green discusses the difficulty in pinning down his diagnosis of the irregular heart rhythm condition, until his use of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
